Opposite effects on inflammation
|
JunB, JunD
|
Anti-inflammatory, through reducing AP-1 activity and miR-155 expression |
[27] |
TGFβ1
|
Worsens lupus erythematous development |
[32] |
APC
|
Pro-inflammatory through the activation of Wnt pathway |
[33] |
Stimulation of cell proliferation and migration
|
TGFβ1
|
Increases the survival of non-irradiated bystander cells |
[37] |
HSPG2
|
Increases chemoresistance of MDA-MB-231/ADM cell line |
[47] |
TGFβ1
|
Inhibits apoptosis induced by endoplasmic reticulum stress |
[54] |
TGFβ1, P53, Bax, Fas
|
Increases lung cancer cell proliferation |
[57] |
PUMA/BBC3, BTG2
|
Inhibits apoptosis and promotes tumor development |
[59] |
Inhibition of cell proliferation and migration
|
eEF1A2
|
Impairs the proliferation of MCF7 cells |
[45] |
CDKN2A
|
Promotes the proliferation of nasopharyngeal carcinoma C666-1 cells |
[48] |
p21(WAF1/CIP1) |
Promotes the proliferation of nasopharyngeal carcinoma cells |
[50] |
TGFβ1
|
Antimetastatic in SW480 colorectal cancer cells |
[28] |
TGFβ1
|
Inhibits epithelium-to-mesenchyme transition of two thyroid carcinoma cell lines |
[51] |
MDGA1, FRAS1
|
decreases renal cancer cell proliferation and migration |
[53] |
eEF1A2
|
Inhibits proliferation and invasion of pancreatic cancer cells |
[56] |
Bcl-2
|
Implicated in waltonitone treatment-induced inhibition of lung cancer cell line proliferation |
[60] |
PI3KCD
|
Inhibits proliferation and invasiveness of glioblastoma cells |
[61] |
CXCR4
|
Increases survival of mice with glioblastoma |
[62] |
TGFβ1, MMP2, E-Cadherin
|
Inhibits proliferation and invasiveness of glioblastoma cells |
[63] |
H-ras
|
Inhibits proliferation of K-562 cells |
[67] |
UQCC2
|
Increases phosphorylative oxidations and decreases tumor development |
[72] |
Prevention of arterial injury
|
TGFβ1
|
Inhibits endothelial cell migration under high concentrations of uric acid |
[76] |
JUNB, MYH9
|
Inhibits vascular smooth muscular cell phenotypic switch |
[77] |